Since its introduction to the US market in 2003, questions have risen as to the safety, long-term consequences, and risk of cardiovascular detriments that e-cigarettes pose to users.
Nicholas C. Johnson, PharmD Candidate, Class of 2021
Advertisement
Articles by Nicholas C. Johnson, PharmD Candidate, Class of 2021
Advertisement
Latest Updated Articles
E-Cigarettes and Vaping: Another Cardiovascular Threat in Disguise?Published: February 5th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Interchangeability Designation to Denosumab Biosimilars Stoboclo and Osenvelt
2
Improving RSV Vaccine Coverage Could Prevent Thousands of Severe Cases in Older Adults
3
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
4
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
5
